• Latest
  • Trending
  • All
  • Egypt
  • Business
  • Local
  • World
WHO ‘strongly recommends’ Pfizer’s Covid pill

WHO ‘strongly recommends’ Pfizer’s Covid pill

April 23, 2022
Magnitude 6.7 earthquake shakes Peru’s Andes

Magnitude 6.7 earthquake shakes Peru’s Andes

November 21, 2026
Araghchi: Iran still hopes diplomacy can end war with US

Araghchi: Iran still hopes diplomacy can end war with US

November 21, 2026
Cairo film festival closes with Golden Pyramid for ‘Four Minus Three’

Cairo film festival closes with Golden Pyramid for ‘Four Minus Three’

November 21, 2026
Former Nvidia CEO Huang agrees to testify at Senate hearing

Former Nvidia CEO Huang agrees to testify at Senate hearing

November 20, 2026
Egypt discusses plan to turn Port Said into sustainable city

Egypt discusses plan to turn Port Said into sustainable city

November 20, 2026
Houthi attacks add to worries over Trump-Saudi nuclear power pact

Houthi attacks add to worries over Trump-Saudi nuclear power pact

November 20, 2026
American detained in Cuba for nearly a decade released

American detained in Cuba for nearly a decade released

November 20, 2026
Student protests held across Europe

Student protests held across Europe

November 20, 2026
Trump, Xi agreed that military AI decisions should involve humans

Trump, Xi agreed that military AI decisions should involve humans

November 20, 2026
Syria blames sabotage for gas-pipeline fire near Deir al-Zour

Qeshm Island explosion linked to munitions disposal

November 20, 2026
  • Advertise
  • Privacy & Policy
  • Contact
Saturday, November 21, 2026
  • Login

Editor-in-Chief

Mohamed Fahmy

Board Chairman

Tarek Lotfy

Egyptian Gazette
No Result
View All Result
  • HOME
  • EGYPT
    • Local
    • Features
  • World
    • National Day
  • Technology
  • BUSINESS
    • Real Estate
    • Automotive
  • SPORTS
  • ENTERTAINMENT
    • Arts
    • Health
    • Lifestyle
    • Travel
    • Tourism
    • Odd News
  • Skyward
    • Snippets from EgyptAir history
  • MORE
    • Multimedia
      • Video
      • Podcast
      • Gallery
    • OP-ED
  • HOME
  • EGYPT
    • Local
    • Features
  • World
    • National Day
  • Technology
  • BUSINESS
    • Real Estate
    • Automotive
  • SPORTS
  • ENTERTAINMENT
    • Arts
    • Health
    • Lifestyle
    • Travel
    • Tourism
    • Odd News
  • Skyward
    • Snippets from EgyptAir history
  • MORE
    • Multimedia
      • Video
      • Podcast
      • Gallery
    • OP-ED
No Result
View All Result
Egyptian Gazette
Home Entertainment Health

WHO ‘strongly recommends’ Pfizer’s Covid pill

by News Wires
April 23, 2022
in Health
Pfizer’s Paxlovid is by far the most potent of existing Covid-19 treatments, the WHO said.

Pfizer’s Paxlovid is by far the most potent of existing Covid-19 treatments, the WHO said.

Share on FacebookWhatsapp

LONDON/GENEVA – The World Health Organization (WHO) said Friday it “strongly recommended” Pfizer’s Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.

The recommendation comes as thousands of people die of COVID-19 every week, despite a waning global infection rate. Of existing COVID-19 treatments, Pfizer’s Paxlovid is by far the most potent, the WHO said according to Reuters.

Other therapies include Merck & Co’s rival pill molnupiravir, Gilead Sciences’ intravenous remdesivir and antibody treatments.

A WHO analysis of two Paxlovid clinical trials involving nearly 3,100 patients suggested it reduced the risk of hospitalisation by 85%. In high-risk patients – those with over 10% risk of hospitalisation – using Paxlovid could lead to 84 fewer hospitalisations per 1,000 patients, the agency said.

“These therapeutics do not replace vaccination. They just give us another treatment option for those patients that do get infected that are at higher risk,” said Janet Diaz, WHO lead on clinical management, referring to patients with underlying chronic conditions, the immunocompromised or unvaccinated.

However, there are challenges that could limit the adoption of Paxlovid. Given it needs to be taken in the early stages of disease to be effective, access to quick and accurate tests are imperative to identify patients.

It can also interact with many common medications, complicating its use. In addition, Paxlovid has not been investigated for use in pregnant women, breastfeeding women or children.

These factors have caused Paxlovid supply to eclipse demand in countries where it has been available for some time.

Pfizer has, and continues to, strike deals to sell the treatment in a number of countries, but details around pricing remain largely confidential.

Earlier this year, the company said it expected Paxlovid to bring in $22 billion in sales in 2022. The US drugmaker has agreed to sell up to 4 million treatment courses to UNICEF for use in 95 low-income countries that encompass just over half the world´s population.

This deal accounts for just over 3% of Pfizer’s projected production of 120 million courses this year.

More than 30 generic drugmakers have also been allowed to manufacture cheaper versions of the drug to sell in the 95 countries, but these copycat versions from quality-assured sources will unlikely be ready in the short term, the WHO said, highlighting the lack of pricing transparency could mean that low- and middle-income countries will be pushed to the end of the queue, as happened with COVID vaccines.

Separately, the WHO also updated its recommendation on Gilead´s remdesivir, saying it should be used in mild or moderate COVID-19 patients at high risk of hospitalisation.

Tags: Covid-19PaxlovidPfizerTop_NewsWorld Health Organization

Discussion about this post

ADVERTISEMENT
egyptian-gazette-logo

The Egyptian Gazette is the oldest English-language daily newspaper in the Middle East.
It was first published on January 26, 1880 and it is part of El Tahrir Printing and Publishing House.

Follow Us

Magnitude 6.7 earthquake shakes Peru’s Andes

Araghchi: Iran still hopes diplomacy can end war with US

Cairo film festival closes with Golden Pyramid for ‘Four Minus Three’

Former Nvidia CEO Huang agrees to testify at Senate hearing

Egypt discusses plan to turn Port Said into sustainable city

  • Advertise
  • Privacy & Policy
  • Contact

Copyrights for © Egyptian Gazette - Administered by Digital Transformation Management.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • EGYPT
    • Local
    • Features
  • World
    • National Day
  • Technology
  • BUSINESS
    • Real Estate
    • Automotive
  • SPORTS
  • ENTERTAINMENT
    • Arts
    • Health
    • Lifestyle
    • Travel
    • Tourism
    • Odd News
  • Skyward
    • Snippets from EgyptAir history
  • MORE
    • Multimedia
      • Video
      • Podcast
      • Gallery
    • OP-ED

Copyrights for © Egyptian Gazette - Administered by Digital Transformation Management.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.